N-(9-Fluorenylmethoxycarbonyl)-O-(2,3,6,2′,3′,4′,6′-hepta-O-acetyl-β-D-lactosyl)-L-serine (CAS 169275-84-7)

N-(9-Fluorenylmethoxycarbonyl)-O-(2,3,6,2′,3′,4′,6′-hepta-O-acetyl-β-D-lactosyl)-L-serine is extensively employed in glycobiology and glycochemistry research due to its crucial role in solid-phase peptide synthesis (SPPS) and the synthesis of glycopeptides. The chemical mechanism involves its utilization as a protected glycosyl amino acid building block in SPPS, enabling the synthesis of complex glycopeptides with precise control over the glycosylation site and linkage. Researchers utilize this compound to prepare glycopeptides for investigating structure-activity relationships, elucidating glycoprotein functions, and studying glycan-mediated biological processes such as protein-protein interactions, cell signaling, and immune responses. Furthermore, N-(9-Fluorenylmethoxycarbonyl)-O-(2,3,6,2′,3′,4′,6′-hepta-O-acetyl-β-D-lactosyl)-L-serine plays a pivotal role in the development of glycopeptide-based vaccines and immunotherapies by enabling the synthesis of glycopeptide antigens for inducing specific immune responses against pathogens or cancer cells. Its application extends to the synthesis of glycoprotein mimetics and glycomimetics, contributing to the design of novel agents, diagnostic tools, and carbohydrate-based materials for various biomedical and biotechnological applications. Overall, this compound serves as a versatile tool in glycoscience research, facilitating the synthesis of complex glycopeptides and advancing our understanding of glycan biology and its implications in health and disease.